UNSPSC 51451605: Oxibendazole

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51451605

Definition

This classification denotes an antihelminthic agent with the molecular formula C12H15N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 022N12KJ0X, chemically known as 2-benzimidazolecarbamic acid, 5-propoxy-, methyl ester but generally known as oxibendazole, which bears US NIH Compound Identifier 4622. European Medicines Agency schedules Oxibendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09521MIG.

Read the full definition

The term OXIBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). OXIBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxibendazole under HS 29339990 and SITC 51577. As of Q4 2014, OXIBENDAZOLE remains the US FDA Preferred Term for this commodity. Oxibendazole bears US NLM identifiers UMLS ID C0069763 and NCI Concept Code C66262. SMILES: CCCOC1=CC2=C(C=C1)N=C(N2)NC(=O)OC.

About UNSPSC 51451605

UNSPSC 51451605 Oxibendazole is a Commodity code for a specific antiparasitic pharmaceutical product, yet state and local opportunities recently posted under this code show little alignment with oxibendazole itself. Recent procurement activity tagged to the code includes pharmaceutical warehouse supply contracts for antibiotics such as Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and acquisition of Naloxone and drug deactivation systems — none of which are oxibendazole. When state and local procurement offices tag opportunities under this code, they are primarily sourcing general pharmaceutical warehouse supply through cooperative purchasing vehicles and piggyback contracts, or acquiring emergency-response and public-health pharmaceuticals for community health initiatives. The issuing bodies span state health departments and county-level public health authorities seeking to stock pharmaceutical inventories through competitive bidding.

Geographic activity centers on Florida and Illinois based on recent postings. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 (Solicitation 26482DPHPREPDB53392) covering antibiotic supplies over a 12-month initial term with renewal options. Seminole County, Florida released an IFB in June 2026 (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually for quarterly delivery to the Seminole County Community Health Building, with a two-year initial term and one-year renewal option. The code shows limited recent activity aligned to oxibendazole specifically; procurement professionals evaluating this code should verify current tagging accuracy with issuing bodies and consider whether general pharmaceutical supply or emergency-response pharmaceuticals match their product or service portfolio.

Quick answers

What is UNSPSC 51451605?

UNSPSC 51451605 is Oxibendazole, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51451605?

UNSPSC 51451605 maps to 1 NIGP code, 26908 Anti-Infective Agents.

On GovTribe

See everything under UNSPSC 51451605

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code